Biomarkers that identify individuals at risk of Alzheimer’s disease (AD) development would be highly valuable. Plasma concentration of amyloid-β (Aβ)—central in the pathogenesis of AD—is a logical candidate, but studies to date have produced conflicting results on its utility.
from Dementia Big http://ift.tt/2dt3Y0d via alcoholic dementia
http://ift.tt/2dFtNNG
No comments:
Post a Comment